Literature DB >> 18807174

p75NTR antagonistic cyclic peptide decreases the size of beta amyloid-induced brain inflammation.

Mina Yaar1, Bennet L Arble, Kenneth B Stewart, Nazer H Qureshi, Neil W Kowall, Barbara A Gilchrest.   

Abstract

Amyloid beta (Abeta) was shown to bind the 75 kD neurotrophin receptor (p75(NTR)) to induce neuronal death. We synthesized a p75(NTR) antagonistic peptide (CATDIKGAEC) that contains the KGA motif that is present in the toxic part of Abeta and closely resembles the binding site of NGF for p75(NTR). In vivo injections of Abeta into the cerebral cortex of B57BL/6 mice together with the peptide produced significantly less inflammation than simultaneous injections of Abeta and a control (CKETIADGAC, scrambled) peptide injected into the contralateral cortex. These data suggest that blocking the binding of Abeta to p75(NTR) may reduce neuronal loss in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18807174      PMCID: PMC2884272          DOI: 10.1007/s10571-008-9298-6

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  23 in total

1.  Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells.

Authors:  S Tan; M Wood; P Maher
Journal:  J Neurochem       Date:  1998-07       Impact factor: 5.372

Review 2.  Neuroinflammation: a potential therapeutic target.

Authors:  Jeffrey M Craft; D Martin Watterson; Linda J Van Eldik
Journal:  Expert Opin Ther Targets       Date:  2005-10       Impact factor: 6.902

Review 3.  The biochemistry of Alzheimer's disease.

Authors:  G J Stege; G J Bosman
Journal:  Drugs Aging       Date:  1999-06       Impact factor: 3.923

4.  The neurotoxicity of amyloid beta protein in aged primates.

Authors:  A C McKee; N W Kowall; J S Schumacher; M F Beal
Journal:  Amyloid       Date:  1998-03       Impact factor: 7.141

5.  Inflammatory signals induce neurotrophin expression in human microglial cells.

Authors:  K Heese; C Hock; U Otten
Journal:  J Neurochem       Date:  1998-02       Impact factor: 5.372

6.  In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment.

Authors:  N W Kowall; A C McKee; B A Yankner; M F Beal
Journal:  Neurobiol Aging       Date:  1992 Sep-Oct       Impact factor: 4.673

7.  Characterization of the toxic mechanism triggered by Alzheimer's amyloid-beta peptides via p75 neurotrophin receptor in neuronal hybrid cells.

Authors:  Emi Tsukamoto; Yuichi Hashimoto; Kohsuke Kanekura; Takako Niikura; Sadakazu Aiso; Ikuo Nishimoto
Journal:  J Neurosci Res       Date:  2003-09-01       Impact factor: 4.164

8.  Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein.

Authors:  M F Knauer; B Soreghan; D Burdick; J Kosmoski; C G Glabe
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

9.  A paradox of immunodeficiency and inflammation in human aging: lessons learned from apoptosis.

Authors:  Sudhir Gupta; Anshu Agrawal; Sudhanshu Agrawal; Houfen Su; Sastry Gollapudi
Journal:  Immun Ageing       Date:  2006-05-19       Impact factor: 6.400

10.  Role of p75 neurotrophin receptor in the neurotoxicity by beta-amyloid peptides and synergistic effect of inflammatory cytokines.

Authors:  Giovanni Perini; Vittorina Della-Bianca; Valeria Politi; Giuliano Della Valle; Ilaria Dal-Pra; Filippo Rossi; Ubaldo Armato
Journal:  J Exp Med       Date:  2002-04-01       Impact factor: 14.307

View more
  5 in total

1.  Role of amyloid β protein receptors in mediating synaptic plasticity.

Authors:  Yu Li; Zhongqing Sun; Qiaoyu Cao; Meiwan Chen; Huanmin Luo; Xi Lin; Fei Xiao
Journal:  Biomed Rep       Date:  2017-02-21

2.  Apoptosis and in vitro Alzheimer disease neuronal models.

Authors:  P Calissano; C Matrone; G Amadoro
Journal:  Commun Integr Biol       Date:  2009

Review 3.  Signaling effect of amyloid-beta(42) on the processing of AbetaPP.

Authors:  Massimo Tabaton; Xiongwei Zhu; George Perry; Mark A Smith; Luca Giliberto
Journal:  Exp Neurol       Date:  2009-09-09       Impact factor: 5.330

Review 4.  In vivo functions of p75NTR: challenges and opportunities for an emerging therapeutic target.

Authors:  Subash C Malik; Elif G Sozmen; Bernat Baeza-Raja; Natacha Le Moan; Katerina Akassoglou; Christian Schachtrup
Journal:  Trends Pharmacol Sci       Date:  2021-07-29       Impact factor: 17.638

Review 5.  Insight into Neurodegenerative Disorder Using Melanocytes as a Model System.

Authors:  Shalini Yadav
Journal:  Ann Indian Acad Neurol       Date:  2020-02-11       Impact factor: 1.383

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.